-transparent.png){kind=logo}
OBJECTIVE To determine the role of human papillomavirus (HPV) of high oncogenic risk in the development of urinary bladder cancer. METHODS 100 patients (72 men and 28 women) aged 38 to 90 years (mean age 65+/-10 years) diagnosed with bladder cancer were examined and underwent treatment. Clinical assessment was complemented by enzyme-linked immunosorbent assays for the presence of antiviral antibodies to herpes simplex virus (HSV) type 1 and type 2, cytomegalovirus (CMV), Epstein-Barr virus (EBV), urethra scraping for detecting high oncogenic risk HPV. Tumor tissue was sampled for PCR virus detection. Semi-quantitative analysis was used to evaluate the components of lymphocyte-plasmocyte and leukocyte infiltrates and cytopathic changes in tumor tissue. RESULTS There were positive correlations between cytopathic cell changes (koylocytosis and intranuclear inclusions, as manifestations of HPV) and the level of antiviral antibodies, the presence of viruses in the tumor, as well as with the components of the lymphoid-plasmocyte infiltrate. Negative correlations were found between the presence of papillomatosis and the above changes. CONCLUSIONS Human papillomavirus is believed to be a trigger for the initiation of a tumor in young patients with a latent infection (CMV and EBV, HSV, HPV). Cytopathic changes (kylocytosis and intranuclear inclusions) were associated with the activity and morphological features of herpes-viral infections. Their degree varied depending on the stage of the process, but not on the anaplasia degree. Papillomatosis is associated with a more favorable course of the tumor process.
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 2012,
British journal of cancer,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 1994,
Urologia internationalis,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
February 2020,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 2017,
Indian journal of medical microbiology,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 2019,
Brazilian oral research,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 2022,
Frontiers in cellular and infection microbiology,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
September 2020,
Pathology, research and practice,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
August 2013,
Archives of pathology & laboratory medicine,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 1997,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
O B Loran, and
L A Sinyakova, and
L V Gundorova, and
V A Kosov, and
I V Kosova, and
I E Pogodina, and
D N Kolbasov
January 1997,
International urogynecology journal and pelvic floor dysfunction,
